CRISPR Therapeutics (CRSP) Stock Price & Financial Analysis
CRISPR Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About CRISPR Therapeutics
What is the current stock price for CRSP?
As of the latest trading session, CRSP stock trades at $48.55. The 52-week range is $34.87–$78.48, with a day range of $47.20–$49.06.
What is the P/E ratio for CRSP?
The P/E ratio (Price-to-Earnings) for CRSP is shown in the Key Statistics section. This valuation metric helps compare CRISPR Therapeutics AG to industry peers.
Does CRSP pay dividends?
CRISPR Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRSP?
Based on 1 analyst, the consensus for CRSP is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CRSP?
CRISPR Therapeutics's market capitalization is $4.66B, classifying it as a mid-cap company. CRISPR Therapeutics operates in the Healthcare sector within the Biotechnology industry.